Arch Therapeutics, Inc.
ARTHDelisted- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001537561
Arch Therapeutics, Inc. was delisted in 2022; its insiders filed their last Form 4 on Sep 8, 2023; 1 institution reported holding it in 13F filings for Q3 2022, worth $0 in total; no superinvestor held it.
Holders of 5% or more of ARTH
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Arch Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Arch Therapeutics, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Arch Therapeutics, Inc., newest first.
No Schedule 13D or 13G filings on Arch Therapeutics, Inc. are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Arch Therapeutics, Inc. shares.
No Form 144 notices for Arch Therapeutics, Inc. are on file.